<DOC>
	<DOCNO>NCT00179283</DOCNO>
	<brief_summary>This randomize , double-blind , active control , 8-week , flexible dose study sertraline vs. venlafaxine Extended Release acute treatment Major Depression male female outpatient site recruit 15-20 patient . Subjects randomize 1:1 ratio receive either sertraline venlafaxine XR base computer-generated randomized list .</brief_summary>
	<brief_title>Sertraline vs. Venlafaxine XR</brief_title>
	<detailed_description>This randomize , double-blind , active control , 8-week , flexible dose study sertraline vs. venlafaxine XR acute treatment Major Depression male female outpatient site recruit 15-20 patient . Subjects randomize 1:1 ratio receive either sertraline venlafaxine XR base computer-generated randomized list . The primary objective study : assess comparative safety tolerability sertraline venlafaxine XR ass number severity discontinuation symptom time termination taper end acute treatment sertraline vs. venlafaxine XR .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Single Recurrent Episode MDD without psychotic feature Additional diagnosis permit identified secondary diagnosis 18 17item HamD item 1 ( depressed mood ) score 2 Current past diagnosis Bipolar Disorder Any history current psychotic disorder Current psychotic symptom , include current delusional depression Current diagnosis delirium dementia Alcohol drug abuse dependence last 6 month currently Schizoid , Schizotypal , Borderline Personality Disorder Nonresponse sertraline least 150mg 4 week , venlafaxine XR least 225mg 4 week , nonresponse 2 antidepressant current episode Use antidepressant within 2 week baseline ( 4 week fluoxetine ) Use herbal and/or homeopathic remedy concomitantly within 2 week baseline exclude vitamin mineral supplement Use within 1 week baseline concomitant use psychotropics exception zolpidem zopiclone PRN sleep Use within 4 week baseline benzodiazepine take regular , daily basis ( PRN use acceptable long none week lead randomization ) Score 3 4 suicide item , item 3 HamD scale screen baseline visit Participation study concomitantly within 90 day prior entry study Treatment monoamine oxidase inhibitor within 14 day baseline Treatment electroconvulsive therapy within 30 day baseline Previous history intolerance hypersensitivity and/or venlafaxine XR Likelihood require treatment study period drug permit study protocol Presence serious and/or unstable medical condition Abnormal laboratory result Positive pregnancy test and/or nurse woman fertile woman practice effective method birth control History seizure disorderexcluding febrile seizure childhood Any condition investigator 's judgement might increase risk subject decrease chance obtain satisfactory data Mental condition render subject unable understand procedure Unable and/or unlikely comprehend and/or follow protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>